Related Experiment Videos
[Advances and prospect of receptor pharmacology]
Sheng Li Ke Xue Jin Zhan [Progress in Physiology]
|April 1, 1984
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
[Central role of surgical management in the diagnosis and treatment of gastroesoph- ageal reflux disease and its indications decision-making framework].
Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery·2025
NOVEL GENETIC FINDINGS IN A CHINESE FAMILY WITH EARLY-ONSET FEMALE-RELATED TYPE 2 DIABETES.
Acta endocrinologica (Bucharest, Romania : 2005)·2019
[Expression and regulation of milk protein gene in mammalia].
Sheng li ke xue jin zhan [Progress in physiology]·1995
[On the central inhibition action of tetrahydroberberine without relevance to GABA receptors].
Sheng li xue bao : [Acta physiologica Sinica]·1994
[Effects of epidermal growth factor on growth and differentiation of rat granulosa cells].
Sheng li xue bao : [Acta physiologica Sinica]·1993
Effects of monoclonal antibody anti-EGF receptor on human nasopharyngeal carcinoma cell and other tumor cells.
Science in China. Series B, Chemistry, life sciences & earth sciences·1990
[Nitric Oxide Signaling Pathway and Vascular Activity].
Sheng li ke xue jin zhan [Progress in physiology]·2018
[The Regulation Effects of Carbon Monoxide in Cardiovascular Systems].
Sheng li ke xue jin zhan [Progress in physiology]·2018
[Research Progress in the Neurobiological Effects of Hydrogen Sulfide].
Sheng li ke xue jin zhan [Progress in physiology]·2018
[Adipocytic Endogenous Hydrogen Sulfide-Function,Regulation and Diseases].
Sheng li ke xue jin zhan [Progress in physiology]·2018
[Role Ofhydrogen Sulfide on Inflammatory Immune Disorders in Cardiovascular Diseases].
Sheng li ke xue jin zhan [Progress in physiology]·2018
[Research Advances in Hydrogen Sulfide and Diabetes Mellitus as Well as Diabetic Complications].
Sheng li ke xue jin zhan [Progress in physiology]·2018
Construction strategies and cutting-edge advances in oral nanozyme delivery systems.
Journal of materials chemistry. B·2026
A Biweekly GLP-1R Agonist Designed With Drug-Free Intervals for Enhanced Efficacy, Receptor Homeostasis and Gastrointestinal Tolerability.
Diabetes, obesity & metabolism·2026